Ekkehard Schütz, Howard B. Urnovitz, et al. “Quantifying copy number variations in cell-free DNA for potential clinical utility from a large prostate cancer cohort”, J Clin Oncol 31, 2013 (suppl; abstr 5072).

Prostate cancer (PrCa) is the most frequent non-dermatological malignancy in the male population. Genomic instability resulting in copy number variation (CNV) is a hallmark of malignant transformation. CNV traces from tumors in cell-free DNA (cfDNA) of prostate cancer patients may be identified through massive parallel sequencing (MPS) of serum DNA. These CNV traces may be biomarkers of cancer with clinical applications for screening and follow-up.

Read the full text on: http://meetinglibrary.asco.org/content/114650-132